SCHEMBL6489263

SCHEMBL6489263

O=Cc1ccc2c(c1)Oc1ccccc1O2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
AHR P35869 3/20 0.48
KIF11 P52732 2/20 0.44
CYP2A6 P11509 2/20 0.42
NTSR1 P30989 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41
KDM4E B2RXH2 2/20 0.40
PTGS2 P35354 1/20 0.40
RAB9A P51151 1/20 0.40
ALOX5 P09917 1/20 0.38
ELANE P08246 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 1/20 0.36
TTR P02766 1/20 0.36
IP6K1 Q92551 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23775788 0.93 ALDH1A1 (0.59) ALDH1A1HSD17B10TDP1AHRKIF11
SCHEMBL5571073 0.85 SMN1; SMN2 (0.53) ALDH1A1HSD17B10TDP1KDM4ERAB9A
SCHEMBL7186528 0.81 ALDH1A1 (0.52) ALDH1A1HSD17B10TDP1AHRKIF11
SCHEMBL10512849 0.78 AHR (0.48) ALDH1A1TDP1AHRRAB9AALOX5
SCHEMBL30811568 0.77 ALOX5 (0.59) ALDH1A1HSD17B10TDP1KIF11RAB9A
SCHEMBL28230706 0.77 ALOX5 (0.64) ALDH1A1HSD17B10TDP1KIF11RAB9A
SCHEMBL27298809 0.77 MAOA (0.59) ALDH1A1HSD17B10TDP1KIF11CYP2A6
SCHEMBL18536089 0.77 CYP2A6 (0.55) ALDH1A1HSD17B10TDP1CYP2A6RAB9A
SCHEMBL11557550 0.77 ALDH1A1 (0.41) ALDH1A1HSD17B10TDP1AHRKIF11
SCHEMBL27344293 0.77 ALOX5 (0.59) ALDH1A1HSD17B10TDP1KIF11RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6858732-B2 Photochromic benzodioxine fused naphthopyran compounds, compositions and articles containing those naphthopyran compounds VISION-EASE LENS, INC. (US) 2005-02-22 US disclosed
WO-2003074528-A1 PHOTOCHROMIC BENZODIOXINE - FUSED NAPHTHOPYRAN COMPOUNDS AND COMPOSITIONS AND ARTICLES CONTAINING THEM VISION-EASE LENS, INC. (US) 2003-09-12 WO disclosed
US-20030168645-A1 Photochromic benzodioxine fused naphthopyran compounds, compositions and articles containing those naphthopyran compounds VISION-EASE LENS, INC. 2003-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030168645-A1 Photochromic benzodioxine fused naphthopyran compounds, compositions and articles containing those naphthopyran compounds NDC1, BRIX1, NR2E3 ALDH1A1 1573/4885HSD17B10 2267/4885TDP1 3018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.